SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 71.93 |
| Enterprise Value ($M) | 23.12 |
| Book Value ($M) | 197.91 |
| Book Value / Share | 3.82 |
| Price / Book | 0.36 |
| NCAV ($M) | 164.03 |
| NCAV / Share | 3.17 |
| Price / NCAV | 0.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.98 |
| Current Ratio | 13.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 189.62 |
| Assets | 223.50 |
| Liabilities | 25.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | BML Investment Partners, L.P. | 6.30 | ||
| 13G/A | ArrowMark Colorado Holdings LLC | 7.08 | 34.38 | |
| 13G/A | BlackRock, Inc. | 2.30 | -64.02 | |
| 13G/A | Jpmorgan Chase & Co | 0.00 | -99.58 | |
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 | |
| 13G/A | Citadel Advisors Llc | 2.40 | ||
| 13G/A | Boxer Capital, LLC | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 4.70 | -12.65 | |
| 13G/A | State Street Corp | 1.41 | 11.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 24,610 | 142,026 | 17.33 | |
| 30,242 | 183,604 | 16.47 | |
| 35,074 | 186,512 | 18.81 | |
| 21,669 | 132,357 | 16.37 | |
| 32,088 | 386,648 | 8.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PHAT – Phathom Pharmaceuticals, Inc. | PHVS – Pharvaris N.V. |
| PLRX – Pliant Therapeutics, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated |
Financial data and stock pages provided by
Fintel.io